These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 36065799)

  • 21. Aspirin Versus Clopidogrel as Single Antithrombotic Therapy After Transcatheter Aortic Valve Replacement: Insight From the OCEAN-TAVI Registry.
    Kobari Y; Inohara T; Saito T; Yoshijima N; Tanaka M; Tsuruta H; Yashima F; Shimizu H; Fukuda K; Naganuma T; Mizutani K; Yamawaki M; Tada N; Yamanaka F; Shirai S; Tabata M; Ueno H; Takagi K; Watanabe Y; Yamamoto M; Hayashida K
    Circ Cardiovasc Interv; 2021 May; 14(5):e010097. PubMed ID: 34003663
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Challenges in Aortic Stenosis: Review of Antiplatelet/Anticoagulant Therapy Management with Transcatheter Aortic Valve Replacement (TAVR): TAVR with Recent PCI, TAVR in the Patient with Atrial Fibrillation, and TAVR Thrombosis Management.
    Sherwood MW; Vora AN
    Curr Cardiol Rep; 2018 Oct; 20(12):130. PubMed ID: 30311013
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Duration of Antiplatelet Therapy Following Transcatheter Aortic Valve Replacement: Systematic Review and Network Meta-Analysis.
    Kuno T; Yokoyama Y; Briasoulis A; Mori M; Iwagami M; Ando T; Takagi H; Bangalore S
    J Am Heart Assoc; 2021 May; 10(9):e019490. PubMed ID: 33870703
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical Bioprosthetic Heart Valve Thrombosis After Transcatheter Aortic Valve Replacement: Incidence, Characteristics, and Treatment Outcomes.
    Jose J; Sulimov DS; El-Mawardy M; Sato T; Allali A; Holy EW; Becker B; Landt M; Kebernik J; Schwarz B; Richardt G; Abdel-Wahab M
    JACC Cardiovasc Interv; 2017 Apr; 10(7):686-697. PubMed ID: 28385406
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antithrombotic strategies after transcatheter aortic valve implantation: Insights from a network meta-analysis.
    Kuno T; Takagi H; Sugiyama T; Ando T; Miyashita S; Valentin N; Shimada YJ; Kodaira M; Numasawa Y; Kanei Y; Hayashida K; Bangalore S
    Catheter Cardiovasc Interv; 2020 Aug; 96(2):E177-E186. PubMed ID: 31609071
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vascular closure after transfemoral transcatheter aortic valve replacement: Further randomized trials are justified.
    Hillegass WB
    Catheter Cardiovasc Interv; 2023 Apr; 101(5):965-966. PubMed ID: 36950827
    [No Abstract]   [Full Text] [Related]  

  • 27. Cochrane corner: transcatheter aortic valve implantation versus surgical aortic valve replacement for severe aortic stenosis in people with low surgical risk.
    Kolkailah AA; Doukky R; Pelletier MP; Volgman AS; Kaneko T; Nabhan AF
    Heart; 2020 Jul; 106(14):1043-1045. PubMed ID: 32482670
    [No Abstract]   [Full Text] [Related]  

  • 28. Antithrombotic therapy in patients undergoing transcatheter aortic valve implantation.
    Nijenhuis VJ; Brouwer J; Søndergaard L; Collet JP; Grove EL; Ten Berg JM
    Heart; 2019 May; 105(10):742-748. PubMed ID: 30867148
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antiplatelet strategy after transcatheter aortic valve replacement: an updated meta-analysis.
    Ma X; Xu Z; Li J; Zhao D; Kong X; Ma J; Ma H; Yun Y; Sun L; Zhang Y; Wei D; Jiao Q; Zou C; Wang Z
    J Cardiovasc Surg (Torino); 2019 Oct; 60(5):624-632. PubMed ID: 31486613
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Randomized Trial of Aspirin Versus Warfarin After Transcatheter Aortic Valve Replacement in Low-Risk Patients.
    Rogers T; Shults C; Torguson R; Shea C; Parikh P; Bilfinger T; Cocke T; Brizzio ME; Levitt R; Hahn C; Hanna N; Comas G; Mahoney P; Newton J; Buchbinder M; Moreno R; Zhang C; Craig P; Asch FM; Weissman G; Garcia-Garcia HM; Ben-Dor I; Satler LF; Waksman R
    Circ Cardiovasc Interv; 2021 Jan; 14(1):e009983. PubMed ID: 33423540
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Post-Discharge Antithrombotic Therapy Following Transcatheter Aortic Valve Implantation in Australian Patients.
    Sotade OT; Jorm LR; Kushwaha VV; Yu J; Sedrakyan A; Falster MO; Pearson SA
    Heart Lung Circ; 2022 Aug; 31(8):1144-1152. PubMed ID: 35637093
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dual Anti-platelet Therapy After Transcatheter Aortic Valve Implantation: Double Trouble?
    Rahman F; Kayani WT; Birnbaum Y; Jneid H
    Cardiovasc Drugs Ther; 2022 Dec; 36(6):1239-1241. PubMed ID: 34806150
    [No Abstract]   [Full Text] [Related]  

  • 33. Sex, Antithrombotics, and Outcomes After TAVR: Is There More Difference Within Sexes or Between Them?
    Masiero G; Tarantini G
    JACC Cardiovasc Interv; 2023 May; 16(9):1103-1106. PubMed ID: 37164610
    [No Abstract]   [Full Text] [Related]  

  • 34. Transcatheter aortic valve replacement versus surgery for symptomatic severe aortic stenosis: A reconstructed individual patient data meta-analysis.
    Dowling C; Kondapally Seshasai SR; Firoozi S; Brecker SJ
    Catheter Cardiovasc Interv; 2020 Jul; 96(1):158-166. PubMed ID: 31566902
    [TBL] [Abstract][Full Text] [Related]  

  • 35. TAVR and Thrombosis.
    Trantalis G; Toutouzas K; Latsios G; Synetos A; Brili S; Logitsi D; Penesopoulou V; Tousoulis D
    JACC Cardiovasc Imaging; 2017 Jan; 10(1):86-87. PubMed ID: 28057223
    [No Abstract]   [Full Text] [Related]  

  • 36. Occam's razor in societal guidelines: optimizing antiplatelet therapy after transcatheter aortic valve implantation.
    Vervoort D; Fremes SE
    Eur J Cardiothorac Surg; 2021 Nov; 60(5):1030-1031. PubMed ID: 34173003
    [No Abstract]   [Full Text] [Related]  

  • 37. Transcatheter versus surgical aortic valve replacement in patients at low surgical risk: A meta-analysis of randomized trials and propensity score matched observational studies.
    Witberg G; Lador A; Yahav D; Kornowski R
    Catheter Cardiovasc Interv; 2018 Aug; 92(2):408-416. PubMed ID: 29388308
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of dual antiplatelet therapy versus oral anticoagulation following transcatheter aortic valve replacement: A retrospective single-center registry analysis.
    Holy EW; Kebernik J; Allali A; El-Mawardy M; Richardt G; Abdel-Wahab M
    Cardiol J; 2017; 24(6):649-659. PubMed ID: 28497845
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antithrombotic therapy after transcatheter aortic valve replacement: current perspective.
    Eckstein J; Liu S; Toleva O; Yanagawa B; Verma S; Cheema AN
    Curr Opin Cardiol; 2021 Mar; 36(2):117-124. PubMed ID: 33394711
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transcatheter Aortic Valve Replacement in Low-Risk Patients: A Meta-Analysis of Randomized Controlled Trials.
    Al-Abdouh A; Upadhrasta S; Fashanu O; Elias H; Zhao D; Hasan RK; Michos ED
    Cardiovasc Revasc Med; 2020 Apr; 21(4):461-466. PubMed ID: 31447314
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.